VERACYTE, INC. Investing Cash Flow
VERACYTE, INC. (VCYT) reported Investing Cash Flow of -$141.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-31
- VERACYTE, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$13.54M.
- VERACYTE, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$127.96M.
- VERACYTE, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$5.43M.
- VERACYTE, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $48.26M.
- VERACYTE, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$9.21M.
- VERACYTE, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$56.27M, a 472.39% decline from fiscal 2023.
- VERACYTE, INC. net cash provided by (used in) investing activities for fiscal 2023 was $15.11M.
- VERACYTE, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$29.39M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$13.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | -$141.51M 10-Q · filed 2026-07-31 | -$146.94M derived: sum of 3 quarters · filed 2026-07-31 | -$98.67M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2026-03-31 | -$127.96M 10-Q · filed 2026-05-06 | -$133.39M derived: sum of 2 quarters · filed 2026-05-06 | -$85.13M derived: sum of 3 quarters · filed 2026-05-06 | -$85.35M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-12-31 | -$5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $42.83M derived: sum of 2 quarters · filed 2026-02-26 | $42.61M derived: sum of 3 quarters · filed 2026-07-31 | -$9.21M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $48.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $48.04M derived: sum of 2 quarters · filed 2026-07-31 | -$3.78M 10-Q · filed 2025-11-05 | -$57.92M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-06-30 | -$224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | -$52.04M 10-Q · filed 2026-07-31 | -$106.18M derived: sum of 3 quarters · filed 2026-07-31 | -$108.42M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-03-31 | -$51.82M 10-Q · filed 2026-05-06 | -$105.96M derived: sum of 2 quarters · filed 2026-05-06 | -$108.20M derived: sum of 3 quarters · filed 2026-05-06 | -$110.97M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | -$54.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$56.38M derived: sum of 2 quarters · filed 2026-02-26 | -$59.15M derived: sum of 3 quarters · filed 2026-02-26 | -$56.27M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$5.01M derived: sum of 2 quarters · filed 2025-11-05 | -$2.13M 10-Q · filed 2025-11-05 | -$4.63M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$2.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $108.00K 10-Q · filed 2025-08-07 | -$2.39M derived: sum of 3 quarters · filed 2026-02-26 | -$5.19M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $2.88M 10-Q · filed 2025-05-08 | $381.00K derived: sum of 2 quarters · filed 2026-02-26 | -$2.42M derived: sum of 3 quarters · filed 2026-02-26 | -$6.09M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.30M derived: sum of 2 quarters · filed 2026-02-26 | -$8.97M derived: sum of 3 quarters · filed 2026-02-26 | $15.11M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$6.47M derived: sum of 2 quarters · filed 2024-11-07 | $17.61M 10-Q · filed 2024-11-07 | -$8.82M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | -$3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $20.41M 10-Q · filed 2024-08-07 | -$6.02M derived: sum of 3 quarters · filed 2025-02-28 | $2.78M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $24.08M 10-Q · filed 2024-05-08 | -$2.35M derived: sum of 2 quarters · filed 2025-02-28 | $6.45M derived: sum of 3 quarters · filed 2025-02-28 | -$2.85M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | -$26.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$17.63M derived: sum of 2 quarters · filed 2025-02-28 | -$26.93M derived: sum of 3 quarters · filed 2025-02-28 | -$29.39M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $8.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$500.00K derived: sum of 2 quarters · filed 2023-11-08 | -$2.95M 10-Q · filed 2023-11-08 | -$2.57M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | -$9.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$11.76M 10-Q · filed 2023-08-09 | -$11.38M derived: sum of 3 quarters · filed 2024-02-29 | -$176.83M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | -$2.45M 10-Q · filed 2023-05-05 | -$2.07M derived: sum of 2 quarters · filed 2024-02-29 | -$167.53M derived: sum of 3 quarters · filed 2024-02-29 | -$166.05M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $385.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$165.07M derived: sum of 2 quarters · filed 2024-02-29 | -$163.60M derived: sum of 3 quarters · filed 2024-02-29 | -$739.21M 10-K · filed 2024-02-29 | |
| 2021-09-30 | -$165.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$163.98M derived: sum of 2 quarters · filed 2022-11-03 | -$739.59M 10-Q · filed 2022-11-03 | -$740.48M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$574.13M 10-Q · filed 2022-08-03 | -$575.02M derived: sum of 3 quarters · filed 2023-03-01 | -$576.66M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | -$575.61M 10-Q · filed 2022-05-04 | -$576.50M derived: sum of 2 quarters · filed 2023-03-01 | -$578.13M derived: sum of 3 quarters · filed 2023-03-01 | -$578.78M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$888.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$2.52M derived: sum of 2 quarters · filed 2023-03-01 | -$3.17M derived: sum of 3 quarters · filed 2023-03-01 | -$3.84M 10-K · filed 2023-03-01 | |
| 2020-09-30 | -$1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$2.28M derived: sum of 2 quarters · filed 2021-11-09 | -$2.95M 10-Q · filed 2021-11-09 | -$44.05M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | -$649.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$1.31M 10-Q · filed 2021-07-29 | -$42.41M derived: sum of 3 quarters · filed 2022-02-28 | -$42.64M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | -$665.00K 10-Q · filed 2021-05-10 | -$41.77M derived: sum of 2 quarters · filed 2022-02-28 | -$41.99M derived: sum of 3 quarters · filed 2022-02-28 | -$42.65M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | -$41.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$41.33M derived: sum of 2 quarters · filed 2022-02-28 | -$41.98M derived: sum of 3 quarters · filed 2022-02-28 | -$42.73M 10-K · filed 2022-02-28 | |
| 2019-09-30 | -$226.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$884.00K derived: sum of 2 quarters · filed 2020-11-02 | -$1.63M 10-Q · filed 2020-11-02 | -$2.09M derived: sum of 4 quarters · filed 2021-02-22 | |
| 2019-06-30 | -$658.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$1.41M 10-Q · filed 2020-07-30 | -$1.86M derived: sum of 3 quarters · filed 2021-02-22 | -$2.52M derived: sum of 4 quarters · filed 2021-02-22 | |
| 2019-03-31 | -$749.00K 10-Q · filed 2020-05-06 | -$1.20M derived: sum of 2 quarters · filed 2021-02-22 | -$1.86M derived: sum of 3 quarters · filed 2021-02-22 | -$2.40M derived: sum of 4 quarters · filed 2021-02-22 | |
| 2018-12-31 | -$454.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | -$1.11M derived: sum of 2 quarters · filed 2021-02-22 | -$1.65M derived: sum of 3 quarters · filed 2021-02-22 | -$1.87M 10-K · filed 2021-02-22 | |
| 2018-09-30 | -$659.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | -$1.19M derived: sum of 2 quarters · filed 2019-10-22 | -$1.42M 10-Q · filed 2019-10-22 | -$1.72M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-30 | -$534.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | -$761.00K 10-Q · filed 2019-07-30 | -$1.06M derived: sum of 3 quarters · filed 2020-02-25 | -$1.79M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-03-31 | -$227.00K 10-Q · filed 2019-04-30 | -$527.00K derived: sum of 2 quarters · filed 2020-02-25 | -$1.25M derived: sum of 3 quarters · filed 2020-02-25 | ||
| 2017-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$1.03M derived: sum of 2 quarters · filed 2020-02-25 | -$1.31M 10-K · filed 2020-02-25 | -$1.20M 10-K · filed 2018-02-27 | |
| 2017-09-30 | -$727.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | -$1.01M 10-Q · filed 2018-10-29 | |||
| 2017-06-30 | -$288.00K 10-Q · filed 2018-07-23 | ||||
| 2016-12-31 | -$4.21M 10-K · filed 2019-02-25 | -$4.21M 10-K · filed 2018-02-27 | |||
| 2015-12-31 | -$6.70M 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |